183 related articles for article (PubMed ID: 30684597)
1. Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: Statistical optimization, trans-tympanic permeation and in vivo evaluation.
Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
Int J Pharm; 2019 Mar; 559():201-209. PubMed ID: 30684597
[TBL] [Abstract][Full Text] [Related]
2. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment.
Al-Mahallawi AM; Khowessah OM; Shoukri RA
Int J Pharm; 2014 Sep; 472(1-2):304-14. PubMed ID: 24971692
[TBL] [Abstract][Full Text] [Related]
3. Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.
Al-Mahallawi AM; Khowessah OM; Shoukri RA
Int J Pharm; 2017 Apr; 522(1-2):157-164. PubMed ID: 28279741
[TBL] [Abstract][Full Text] [Related]
4. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
6. Formulations for trans-tympanic antibiotic delivery.
Khoo X; Simons EJ; Chiang HH; Hickey JM; Sabharwal V; Pelton SI; Rosowski JJ; Langer R; Kohane DS
Biomaterials; 2013 Jan; 34(4):1281-8. PubMed ID: 23146430
[TBL] [Abstract][Full Text] [Related]
7. Engineered triamcinolone acetonide loaded glycerosomes as a novel ear delivery system for the treatment of otitis media.
Magdy M; Elmowafy E; El-Assal MIA; Ishak RAH
Int J Pharm; 2022 Nov; 628():122276. PubMed ID: 36270555
[TBL] [Abstract][Full Text] [Related]
8. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate.
Hasan AA; Sabry SA; Abdallah MH; El-Damasy DA
Pharm Dev Technol; 2016 Sep; 21(6):655-63. PubMed ID: 25915180
[TBL] [Abstract][Full Text] [Related]
10. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
11. Glycerospanlastics: State-of-the-art two-in-one nano-vesicles for boosting ear drug delivery in otitis media treatment.
Magdy M; Elmowafy E; Elassal M; Ishak RAH
Int J Pharm; 2023 Oct; 645():123406. PubMed ID: 37703960
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
Elsaid N; Somavarapu S; Jackson TL
Exp Eye Res; 2014 Apr; 121():121-9. PubMed ID: 24530465
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
14. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
Jacob S; Nair AB; Al-Dhubiab BE
J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
[TBL] [Abstract][Full Text] [Related]
16. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology.
Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP
Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
18. Collagen loaded nano-sized surfactant based dispersion for topical application: formulation development, characterization and safety study.
Ahmad I; Akhter S; Ahmad MZ; Shamim M; Rizvi MA; Khar RK; Ahmad FJ
Pharm Dev Technol; 2014 Jun; 19(4):460-7. PubMed ID: 23675949
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel.
Bruk LA; Dunkelberger KE; Khampang P; Hong W; Sadagopan S; Alper CM; Fedorchak MV
PLoS One; 2020; 15(10):e0240535. PubMed ID: 33045028
[TBL] [Abstract][Full Text] [Related]
20. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution.
Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI
Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
